These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 26365931
1. Evaluation of cytokines and soluble adhesion molecules in patients with newly diagnosed acute myeloid leukemia: the role of TNF-alpha and FLT3-ITD. Kupsa T, Vanek J, Vasatova M, Karesova I, Zak P, Jebavy L, Horacek JM. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):94-9. PubMed ID: 26365931 [Abstract] [Full Text] [Related]
2. Serum levels of soluble adhesion molecules in newly diagnosed acute myeloid leukemia and in complete remission suggest endothelial cell activation by myeloblasts. Kupsa T, Vanek J, Pavel Z, Jebavy L, Horacek JM. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):92-99. PubMed ID: 27833171 [Abstract] [Full Text] [Related]
7. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H. Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943 [Abstract] [Full Text] [Related]
8. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM. Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998 [Abstract] [Full Text] [Related]
11. Multi-analytical evaluation of serum levels of cytokines and adhesion molecules in patients treated for acute myeloid leukemia using biochip array technology. Horacek JM, Vasatova M, Kupsa T, Jebavy L, Zak P. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):277-9. PubMed ID: 24089084 [Abstract] [Full Text] [Related]
12. Serum cytokine and adhesion molecule profile differs in newly diagnosed acute myeloid and lymphoblastic leukemia. Horacek JM, Kupsa T, Vasatova M, Jebavy L, Zak P. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):299-301. PubMed ID: 25363727 [Abstract] [Full Text] [Related]
15. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T. Clin Cancer Res; 2005 Feb 15; 11(4):1416-24. PubMed ID: 15746041 [Abstract] [Full Text] [Related]
16. [FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia]. Han YL, Zhang SJ, Qiao C, Dai D, Sun XM, Xu YL, Qian SX, Xu W, Wang JS, Li JY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct 15; 17(5):1135-9. PubMed ID: 19840437 [Abstract] [Full Text] [Related]
17. [FLT3 mutations in children with acute myeloid leukemia: a single center study]. Ruan M, Wang YQ, Zhang L, Liu TF, Liu F, Liu XM, Zhang JY, Zou Y, Chen YM, Zhu XF. Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov 15; 13(11):863-6. PubMed ID: 22099191 [Abstract] [Full Text] [Related]
18. [Correlation of Fms-like tyrosine kinase 3 (FLT3) gene expression to FLT3/internal tandem duplication mutation in peripheral blood of acute myeloid leukemia.]. Xu B, Shi PC, Song XY, Tang JH, Zhou SY. Ai Zheng; 2009 Jun 15; 28(6):632-6. PubMed ID: 19635202 [Abstract] [Full Text] [Related]